These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 16382021)
41. Alpha-interferon therapy increases serum beta2-microglobulin levels in hemodialysis patients. Espinosa M; Martin-Malo A; Alvarez de Lara MA; Navarro MD; Aljama P Clin Nephrol; 2001 Nov; 56(5):378-81. PubMed ID: 11758008 [TBL] [Abstract][Full Text] [Related]
42. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103 [TBL] [Abstract][Full Text] [Related]
43. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study. Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969 [TBL] [Abstract][Full Text] [Related]
44. Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis. Arkouche W; Juillard L; Delawari E; Lasne Y; Combarnous F; Sibaï-Galland R; Traeger J; Laville M; Fouque D Am J Kidney Dis; 1999 Nov; 34(5):839-44. PubMed ID: 10561139 [TBL] [Abstract][Full Text] [Related]
45. Frequency and prognostic significance of QT prolongation in chronic renal failure patients. Voiculescu M; Ionescu C; Ismail G Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617 [TBL] [Abstract][Full Text] [Related]
46. Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Kovesdy CP; Trivedi BK; Anderson JE Adv Chronic Kidney Dis; 2006 Apr; 13(2):183-8. PubMed ID: 16580621 [TBL] [Abstract][Full Text] [Related]
48. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study. Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A; Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379 [TBL] [Abstract][Full Text] [Related]
49. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973 [TBL] [Abstract][Full Text] [Related]
50. Serum low-molecular-weight proteins in haemodialysis patients: effect of residual renal function. Brown PH; Kalra PA; Turney JH; Cooper EH Nephrol Dial Transplant; 1988; 3(2):169-73. PubMed ID: 2459634 [TBL] [Abstract][Full Text] [Related]
51. Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients? Caravaca F; Martín MV; Barroso S; Ruiz B; Hernández-Gallego R Nephrol Dial Transplant; 2006 Jun; 21(6):1575-81. PubMed ID: 16484235 [TBL] [Abstract][Full Text] [Related]
52. Residual renal function and mortality risk in hemodialysis patients. Shemin D; Bostom AG; Laliberty P; Dworkin LD Am J Kidney Dis; 2001 Jul; 38(1):85-90. PubMed ID: 11431186 [TBL] [Abstract][Full Text] [Related]
53. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730 [TBL] [Abstract][Full Text] [Related]
54. [Factors which influence phosphorus removal in hemodialysis]. Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879 [TBL] [Abstract][Full Text] [Related]
55. Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival. Bechtel JF; Detter C; Fischlein T; Krabatsch T; Osswald BR; Riess FC; Scholz F; Schönburg M; Stamm C; Sievers HH; Bartels C Ann Thorac Surg; 2008 Jan; 85(1):147-53. PubMed ID: 18154800 [TBL] [Abstract][Full Text] [Related]
56. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Unruh ML; Evans IV; Fink NE; Powe NR; Meyer KB; Am J Kidney Dis; 2005 Dec; 46(6):1107-16. PubMed ID: 16310577 [TBL] [Abstract][Full Text] [Related]
57. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania. Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358 [TBL] [Abstract][Full Text] [Related]
59. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis. Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292 [TBL] [Abstract][Full Text] [Related]
60. High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Díez JJ; Estrada P; Bajo MA; Fernández-Reyes MJ; Grande C; del Peso G; Heras M; Molina A; Iglesias P; Sánchez-Villanueva R; Selgas R Am J Nephrol; 2009; 30(3):244-52. PubMed ID: 19468209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]